'Anti-obesity medications' or 'medications to treat obesity' instead of 'weight loss drugs' – why language matters – an official statement of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO) and the Brazilian Society of Endocrinology and Metabolism (SBEM)

MLA

Bruno Halpern, et al. “‘Anti-Obesity Medications’ or ‘Medications to Treat Obesity’ Instead of ‘Weight Loss Drugs’ – Why Language Matters – an Official Statement of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO) and the Brazilian Society of Endocrinology and Metabolism (SBEM).” Archives of Endocrinology and Metabolism, vol. 67, no. 4, Oct. 2023. EBSCOhost, https://doi.org/10.20945/2359-4292-2023-0174.

APA

Bruno Halpern, Marcio C. Mancini, Simone van de Sande-Lee, & Paulo Augusto Carvalho Miranda. (2023). “Anti-obesity medications” or “medications to treat obesity” instead of “weight loss drugs” – why language matters – an official statement of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO) and the Brazilian Society of Endocrinology and Metabolism (SBEM). Archives of Endocrinology and Metabolism, 67(4). https://doi.org/10.20945/2359-4292-2023-0174

Chicago

Bruno Halpern, Marcio C. Mancini, Simone van de Sande-Lee, and Paulo Augusto Carvalho Miranda. 2023. “‘Anti-Obesity Medications’ or ‘Medications to Treat Obesity’ Instead of ‘Weight Loss Drugs’ – Why Language Matters – an Official Statement of the Brazilian Association for the Study of Obesity and Metabolic Syndrome (ABESO) and the Brazilian Society of Endocrinology and Metabolism (SBEM).” Archives of Endocrinology and Metabolism 67 (4). doi:10.20945/2359-4292-2023-0174.